secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2022-08-01T23:59:59+00:00
Accession:  0001213900-22-043166
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband receives Canadian patent allowance for AVERSA abuse deterrent transdermal technology
--------------------------------------------------------------------------------

- Canadian Intellectual Property Office issued Notice of Allowance for patent CA 2937649 covering AVERSA transdermal abuse deterrent technology.
- Patent adds to existing US and Mexico patents, providing IP protection across North America.
- Lead product AVERSA Fentanyl estimated to have peak annual US sales potential of $80M-$200M.
- AVERSA technology aims to deter abuse, diversion, and accidental exposure of opioids like fentanyl in transdermal patches.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390022043166/0001213900-22-043166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390022043166/ea163643-8k_nutriband.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-043166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer